A Prediction Model in Pregnant Women With Aplastic Anemia

Recruiting now

Conditions studied: Aplastic Anemia, Pregnancy, Prediction Model

In brief

Aplastic anemia (AA) is a rare haematologic disorder characterized by bone marrow failure and pancytopenia. Its occurrence during pregnancy is exceedingly rare but poses significant risks, including maternal hemorrhage, infections, and perinatal complications such as preterm birth and fetal growth restriction. Consequently, pregnancy with AA is highly perilous for both mothers and infants. Early management is critical to ensure the health of both the mother and the baby. However, there are currently no predictive tools available to assess adverse outcomes in pregnant women with AA. Our center plans to conduct a multicenter, combined retrospective and prospective cohort study.

Key facts

Study ID

NCT07101770

Run by

Peking University People's Hospital

People needed

300

Starts

2025-11-27

Expected to finish

2030-12-31

Last updated by the study team

2025-12-01

Who can join

Age: 20 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• pregnant women who had aplastic anemia before pregnancy
• pregnant women with newly diagnosed aplastic anemia during pregnancy

You may not qualify if…

• age less than 20 years
• without coagulation series results
• termination of pregnancy before 20 weeks of gestation
• multiple pregnancy

Where it is running

• Peking University People's Hospital — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.